HanAll Biopharma and Daewoong Pharmaceutical Invest $1M USD in Alloplex Biotherapeutics
HanAll Biopharma and Daewoong Pharmaceutical Invest $1M USD in Alloplex Biotherapeutics
HanAll Biopharma Reports Second Quarter 2021 Results
HanAll Biopharma Reports Second Quarter 2021 Results
HanAll Biopharma Submits IND for Second Phase 3 (VELOS-3) of HL036 in Dry Eye Disease
HanAll Biopharma Submits IND for Second Phase 3 (VELOS-3) of HL036 in Dry Eye Disease
HanAll\'s Partner HBM Announces Positive Topline Results from Phase 2 of Batoclimab in MG
HanAll\'s Partner HBM Announces Positive Topline Results from Phase 2 of Batoclimab in MG
HanAll Biopharma Reports First Quarter 2021 Financial Results
HanAll Biopharma Reports First Quarter 2021 Financial Results
HanAll Biopharma Appoints David Hernandez as Vice President of Clinical Development Operations
HanAll Biopharma Appoints David Hernandez as Vice President of Clinical Development Operations